Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

42.78 +0.11 (+0.26%)
Streaming Delayed Price Updated: 3:43 PM EDT, Jul 23, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Bristol-Myers Squibb

< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Microsoft To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
AstraZeneca, Sanofi And Other Pharma Giants Pursue Chinese Deals Despite Rising US-China Strife
The aim is to strengthen their drug pipelines and expand their presence in the world's second-largest pharmaceutical market. 
Via Benzinga
A Glimpse Into The Expert Outlook On Bristol-Myers Squibb Through 4 Analysts
Via Benzinga
3 Defensive Stocks to Shield Your Portfolio in July
Fed Chair Jerome Powell’s cautious economic outlook adds to the allure of defensive stocks offering stable long-term returns 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
7 Value Stocks to Buy at a 52-Week Low in July
Bottom fishers and contrarians take note: each of these seven value stocks to buy is on sale after recently hitting new 52-week lows. 
Via InvestorPlace
What the Options Market Tells Us About Bristol-Myers Squibb
Via Benzinga
High Dividend 50: Bristol-Myers Squibb
This article will examine the prospects of Bristol-Myers as an investment opportunity. 
Via Talk Markets
Bristol-Myers Squibb Unusual Options Activity For July 15
Via Benzinga
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
Spotlight on Bristol-Myers Squibb: Analyzing the Surge in Options Activity
Via Benzinga
How Is The Market Feeling About Bristol-Myers Squibb?
Via Benzinga
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
The Nasdaq tumbled amid chip woes. 
Via Investor's Business Daily
Bristol Myers Squibb Receives European Medicines Agency Validation of Application for Opdivo (nivolumab) plus Yervoy (ipilimumab) for First-Line Treatment of Unresectable or Advanced Hepatocellular Carcinoma
From Bristol Myers Squibb
Via Business Wire
Collect $2,000 in Dividends Per Year by Investing $35,000 in These 3 Stocks
These stocks all pay more than four times the S&P 500 average. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
US Bancorp Posts Upbeat Earnings, Joins Aehr Test Systems, Hancock Whitney And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Got $500? 2 No-Brainer Growth Stocks to Buy and Hold Forever
These businesses are begging to be bought. 
Via The Motley Fool
Week In Review: Foreseen Sells ADC Rights To France's Ipsen In $1 Billion Deal
In other news, Sichuan Biokin Pharma has filed for an IPO on the Hong Kong Exchange; more on the Biosecure Act being pushed by US Speaker of the House Johnson. 
Via Talk Markets
Topics Initial Public Offering
Exposures Securities Market
3 High-Yielding Dividend Stocks Near Their 52-Week Lows
These stocks all yield more than 3%. 
Via The Motley Fool
2 Pharma Stocks to Buy Hand Over Fist This Month
These drugmakers may not be in perfect health right now, but that shouldn't last much longer. 
Via The Motley Fool
3 Under-$10 Biotech Stocks That Could Make You Rich
Discover three under-$10 biotech stocks with potential to make you rich with huge returns on investment through an in-depth analysis. 
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
3 Undervalued Stocks Ready for a Breakout This Summer
Undervalued breakout stocks are heating up this summer. Discover three hidden gems with strong fundamentals ready to outperform the market. 
Via InvestorPlace
3 Popular Stocks Trading at 52 Week Lows
Stocks at 52 week lows could provide value, but it's not always a sure thing. 
Via The Motley Fool
Want $1,000 in Reliable Dividend Income? Invest $11,800 in these 3 Ultra-High-Yield Dividend Stocks.
These three dividend payers could deliver buckets of passive income to patient investors. 
Via The Motley Fool
The 7 Best Warren Buffett Stocks to Buy in July 2024
Some investors may say value investing is dead, but its never a bad time to look at some of the best Warren Buffett stocks to buy 
Via InvestorPlace
3 High-Yield S&P 500 Dividend Stocks That You Can Buy With $100 Right Now
After underperforming the benchmark index these stocks offer high dividend yields that are hard to ignore. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Bristol Myers Squibb to Participate in UBS Virtual Targeted Protein Degradation Day
From Bristol Myers Squibb
Via Business Wire
3 Defensive Stocks to Buy During the Market Dip
Clearway, Bristol-Myers Squibb and Universal Corp. are defensive stocks to buy on the dip, offering stable dividends and significant upside. 
Via InvestorPlace
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With $100 in July
Adding these dividend payers to your portfolio is a nearly certain way to boost your passive income stream. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.